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Key Clinical Message
Low fraction fetal DNA in noninvasive prenatal testing in the context of fetal
growth restriction and multiple congenital anomalies should alert medical
professionals to the possibility of digynic triploidy. Single-nucleotide polymor-
phism microarray can detect the parental origin of triploidy and explain its
mechanism.
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Introduction
Triploidy is a chromosomal anomaly that is seen in 1–2%
of all conceptions and up to 10% of spontaneous abor-
tions [1]. It is classified as diandry when the extra set of
chromosomes is from the father and digyny when the
extra set of chromosomes is of maternal origin. Most
cases of diandry occur as a result of dispermy and less
commonly are caused by nondisjunction during the first
(MI) or the second meiotic division (MII) of spermato-
genesis. On the other hand, most cases of digyny are
caused by errors in MI or MII of oogenesis [2].
Although most triploid conceptions end in first trimes-
ter spontaneous abortions, there are few reports of live
born infants with triploidy, with the longest reported sur-
vival of digynic triploidy at 10 ½ months [3]. Based on
personal communication of the authors of same report,
about half of previously reported 38 triploidy cases were
live-born and lived for a few minutes to 5 days [3]. Nie-
mann-Seyde et al. [4] reported a girl with diandric trip-
loidy who survived for 10 ½ weeks and reviewed the data
on 7 previously reported triploid patients who survived
beyond 2 months of age. Hasegawa et al. [5] described a
girl with digynic triploidy who survived for 46 days and
discussed parental of origin and clinical findings of four
additional triploid (three digynic and one diandric)
infants who survived 4 weeks or more. Parental origin
studies of triploidy showed variable diandric to digynic
ratios [2, 6–8], reflecting ascertainment bias and different
selection criteria [8]. Digyny is associated with asymmet-
ric severe fetal growth restriction (FGR) and a very small
placenta [8, 9]. Diandric triploid fetuses are relatively well
grown or exhibit symmetric FGR accompanied by a large
cystic, often molar, placenta [9].
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Since the introduction of noninvasive prenatal testing
(NIPT) to clinical practice, it has evolved to be a com-
mon screening test for chromosomal aberrations in preg-
nancies complicated by abnormal ultrasound or maternal
serum screens or for advanced maternal age [10]. How-
ever, there is limited data in the utility of NIPT in the
detection of triploidy and the matter has never been
systematically investigated. Here, we present a digynic
triploidy case that escaped diagnosis despite using two
methods of NIPT. Our data suggest that low fraction fetal
DNA in NIPT along with multiple congenital anomalies
and FGR should alert medical professionals to the possi-
bility of digynic triploidy and demonstrate that SNP
microarray can detect the parental origin of triploidy and
its mechanism.
Case Presentation
The proband was born to a 24-year-old G1P0 after a
pregnancy complicated by multiple fetal anomalies. There
was no family history of congenital anomalies, early
infant deaths, or consanguinity. The mother declined first
trimester screening for fetal anomalies and chromosomal
abnormalities. At 18 weeks of gestation, the fetus had
been diagnosed with early-onset FGR, oligohydramnios,
and bilateral brain ventriculomegaly. Severe oligohydram-
nios would have made the amniocentesis technically diffi-
cult and the parents declined the procedure. NIPT on
cell-free fetal DNA (cffDNA) testing at 18 weeks of gesta-
tion could not be interpreted secondary to an insufficient
fraction (1.3%). Repeat ultrasound assessment in our
center at ~22 weeks was notable for asymmetric bilateral
ventriculomegaly, severe FGR (<5th percentile), oligohy-
dramnios (amniotic fluid index was 5th centile), small
chest, a possible right pelvic kidney, and the fetal gender
could not be determined. The mother declined amniocen-
tesis and opted to repeat cffDNA testing at 22 weeks of
gestation, which demonstrated the expected representa-
tion of chromosome 21, 18, and 13 materials, absence of
Y chromosome material, with cffDNA fraction of 5.2%.
At ~33 weeks, the estimated fetal weight was 601 g. The
mother was counseled on the poor prognosis for her fetus
but opted for full obstetric intervention, including poten-
tial cesarean section with full neonatal management. After
one dose of antenatal steroids on the day prior to deliv-
ery, the proband was born via cesarean section for nonre-
assuring fetal status with a 0/8 biophysical profile and
fetal bradycardia. A partial placental abruption, very small
placenta and short, thin cord were noted at the time of
delivery.
At birth, the neonate had no spontaneous respirations
and a heart rate below 80 beats per minute, for which he
was intubated and placed on a respirator, but soon
required high frequency ventilation and nitric oxide.
Despite the NIPT results, the infant was found to have
male genitalia with hypospadias. On physical examina-
tion, all growth parameters were below 3rd centile for
proband’s gestational age. His weight was 590 g (50th
centile for 23 weeks’ gestation), length was 30 cm (50th
centile for 23 weeks’ gestation), and occipitofrontal
circumference was 25 cm (50th centile for 26 weeks’
gestation). Facies showed frontal bossing, hypertelorism, a
bulbous nasal tip, a depressed nasal bridge, micrognathia,
and low set and posteriorly rotated ears. There was cuta-
neous syndactyly of 2–4th toes bilaterally, as well as 3–4th
fingers of the left hand, webbing of all digits of the right
hand, and adducted thumbs bilaterally. His skin was
thin and translucent. A head ultrasound demonstrated
enlarged, dysplastic lateral ventricles with a dysplastic cor-
pus callosum and possible partial thalamic fusion. A skel-
etal survey revealed thin clavicles, gracile ribs and humeri,
and butterfly vertebral bodies in the upper thoracic spine.
An echocardiogram showed a moderate perimembranous
ventricular septal defect (VSD) and atrial-level shunt, a
large patent ductus arteriosus (PDA), and dilation of the
aortic root (Z score +2.3) and ascending aorta (Z score
+3.2). Renal ultrasound showed small kidneys with loss of
normal corticomedullary differentiation with few scattered
microcysts. Ultrasound of the bladder showed an irregular
contour suggestive of trabeculations. Despite maximum
ventilatory support, the neonate’s condition continued to
decline. The family chose to redirect plans to supportive
care and the neonate succumbed to respiratory failure at
16 h of life.
At autopsy, the aforementioned dysmorphic features
were noted (Fig. 1). There was dilatation of the lateral
ventricles and fusion of the thalami. The lungs were small
and hypoplastic and the testes were found intra-abdomi-
nally. The bladder was dilated with thickened wall and
trabeculated mucosa associated with urethral stenosis.
The placenta weighed 51.7 g and had microscopic features
of chronic placental insufficiency including distal villous
hypoplasia and increased syncytial knotting. The umbilical
cord had three vessels with focal obliteration of the
umbilical artery, consistent with flow change due to focal
vascular thrombosis. Testes had immature seminiferous
tubules.
Molecular and Cytogenetic Results
Due to multiple congenital anomalies in the neonate and
discrepancy between the male phenotype and the NIPT
results, FISH analysis was performed on a direct prepara-
tion from a sample of peripheral blood and revealed two
hybridization signals for CEP X and one hybridization
signal for SRY in all 500 nuclei analyzed. Subsequent
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rapid FISH analysis for select loci revealed three copies of
chromosomes 13, 18, and 21 using LSI 13, CEP 18, and
LSI 21, two copies of the X chromosome (CEP X), and
one copy of the Y chromosome (CEP Y). A chromosomal
microarray analysis (CMA), using the Affymetrix
CytoScan HD array was performed with reflex to karyo-
type; the latter confirmed 69,XXY pattern. The CMA of
the proband revealed triploidy as indicated by the pres-
ence of four-allele peak tracks on all autosomes with a
normal Log2 ratio. There were two copies of chromosome
X (Fig. 2) and one copy of chromosome Y as interpreted
from the allele peak tracks, Log2 ratio and smooth signal.
Notably, an apparent copy number neutral region
demonstrating a long contiguous stretch of homozygosity
(LCSH) on chromosome X from bands p22.2 to q24 and
spanning ~106.28 Mb was observed and suggests that the
majority of the length of chromosome X is identical
across all loci. This pattern is consistent with a triploidy
of digynic origin in that the two copies of chromosome X
are uniparental and as by nature the Y chromosome is
paternally derived, the X chromosomes are therefore
maternally attributed. Regions distal to the LCSH include
the pseudoautosomal regions demonstrated a Log2 ratio
and allele peak tracks similar to the pattern seen in all
autosomal chromosomes (Fig. 2). Additionally, regions of
meiotic recombination (cross-over) were observed on
chromosome X encompassing bands p22.33 to p22.2 on
the short arm and bands q24 to q28 on the long arm as
determined by genomic stretches demonstrating heterozy-
gosity. These findings, along with similar changes on the
autosomes, indicate error in nondisjunction during MII
as the most likely mechanism. The CMA also revealed a
maternally inherited 762 kb gain of chromosomal mate-
rial on 9p21.2 (26,456,904–27,218,960;hg19), likely of no
clinical significance. Of note, because of the normalization
algorithm employed during analysis, the detection of trip-
loidy is not typically possible in array platforms contain-
ing solely copy number probes.
Discussion
The results of NIPT in the proband make this case
particularly interesting. Currently, there are four commer-
Figure 1. Autopsy findings in the proband. External examination
demonstrates relative macrocephaly, dysmorphic facies, hypertelorism,
micrognathia, and syndactyly of the third and fourth fingers on left
hand.
Figure 2. Molecular findings in the proband. Chromosomal Microarray Analysis (CMA) data from the X chromosome with a normalized copy
number state ~2 in PAR1 and PAR2, and ~1 across the remainder of the chromosome with a long contiguous stretch of homozygosity observed
proximally, and regions of heterozygosity observed distally.
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cially available noninvasive prenatal tests in the United
States: Natera’s Panorama Prenatal test (NPP),
Sequenom’s MaterniT21 test (SM), Ariosa Diagnostics’s
Harmony test (ADH), and Verinata Health’s Verifi test
(VHV) [11]. For our patient’s mother, the initial NPP
test was not diagnostic due to a low fraction of cffDNA.
The subsequent SM test revealed no Y chromosomal
material, consistent with a normal female fetus. One
possibility for this difference is the type of technology
used in each of these tests. The NPP test uses multiplex
PCR followed by SNP-based targeted sequencing and
analysis of parental genotypes [12], as opposed to the SM
test which uses massively parallel shotgun sequencing and
quantification of the number of reads from each chromo-
some [13]. While both methods allow for accurate deter-
mination of individual chromosomal trisomies, the SM
test uses a comparison among the relative number of
reads from each chromosome. Hence, the SM test may
be at a disadvantage in detecting triploidy, which affects
all of the autosomes equally. In fact, while none of the
other three commercial companies make a claim regard-
ing the detection of triploidy, the NPP test in a recently
published study has been able to correctly identify all
four diandric trisomy cases, while all four digynic cases
tested were found to have low cffDNA fraction after
adjusting for maternal weight and gestational age (<4%)
and consequently escaped diagnosis [14]. The small size
of the placenta in digynic triploidy likely contributes to
low cffDNA [14]. The source of cffDNA in maternal
blood is dying cytotrophoblastic cells [15] and its low
fraction reflects low placental mass as seen in digynic
triploidy [14]. The lack of observed Y chromosomal
material in our proband by Sequenom NIPT can be
related to an overestimation of the cffDNA fraction
because of limitation in the quantification method used,
which is based on differentially methylated markers in
fetal and maternal DNA [13]. Furthermore, the reported
accuracy of detecting sex chromosome abnormalities is
lower than autosomal aberrations with overall sensitivity
of 96.2%, false positive rate of 0.3%, and nonreportable
rate of 5% [16]. The small size of Y chromosome and
fewer interrogated genomic regions on Y chromosome
can also lead to a weaker signal-to-noise ratio [16]. These
limitations were exacerbated by the triploid karyotype
composition since the sex chromosome representations
are evaluated as ratios of normalized read counts as com-
pared to the total autosomal read counts. The diagnosis
of digynic triploidy can also be challenging because of
difficulties in performing amniocentesis due to oligohy-
dramnios.
In conclusion, digynic triploidy is difficult to identify
by NIPT due to low cffDNA fraction. SNP microarray
can be an effective tool in determining the mechanism
and parental origin in triploidy. A low cffDNA fraction in
the context of FGR and multiple congenital anomalies
should alert medical professionals to the possibility of
digynic triploidy. The development of highly sensitive
NIPT technologies that combine massively parallel
sequencing and SNP analysis has the potential to improve
the detection of digynic triploidy.
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